(Q46947440)

English

Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential

scientific article published on 12 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

author name string

Harsh Panwar

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

Danielle Calderwood

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

Sunita Grover

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

Brian D Green

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

publication date

12 January 2014

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

European Journal of Nutrition

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

53

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

1465-1474

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

https://scigraph.springernature.com/pub.10.1007/s00394-013-0649-9

0 references

Inhibitory effect of Azadirachta indica A. juss leaf extract on the activities of alpha-amylase and alpha-glucosidase

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

alpha-Glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

α-Glucosidase inhibitors and their use in clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Chemistry, physiological properties, and microbial production of hydroxycitric acid

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

A meta-analysis of probiotic efficacy for gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Identification of lactobacilli by pheS and rpoA gene sequence analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Expression and purification of two Family GH31 α-glucosidases from Bacteroides thetaiotaomicron.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Ecological and evolutionary forces shaping microbial diversity in the human intestine

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

The human gut microbiome: ecology and recent evolutionary changes

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Enzymatic properties of a thermostable α-glucosidase from acidothermophilic crenarchaeon Sulfolobus tokodaii strain 7.

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0649-9

21 January 2018

Influence of alternansucrase-derived oligosaccharides and other carbohydrates on alpha-galactosidase and alpha-glucosidase activity in Bifidobacterium adolescentis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for glycosidase activities of lactic acid bacteria as a biotechnological tool in oenology

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A PCR-based method for identification of lactobacilli at the genus level

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of components from Streptomyces species on alpha-glucosidase and alpha-amilase of different origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

α-Amylase inhibitors: a review of raw material and isolated compounds from plant source

1 reference

https://pubmed.ncbi.nlm.nih.gov/24414142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00394-013-0649-9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24414142

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46947440&oldid=2139404462"